Breedon Aggregates is asset backed, has strong cash flow and will make additional acquisitions to take advantage of a growing sector.
Glaxo appears set to benefit from improved prospects this year and recent renewed speculation that Pfizer might be interested in a bid.
The turnaround at Aviva is progressing well under Mark Wilson’s leadership, while the Friends Life deal significantly strengthens the balance sheet and improves the group’s cash generation.
Poundland offers a compelling European discount growth story, with a number of important announcements in coming weeks.
Laird launched 24 new products and applications last year, helping it achieve design wins in wireless charging and contactless medical and automotive technology.